LOTIS-5: Updated safety run-in results from Phase 3 trial demonstrate 80% ORR, 50% CR rate and median DoR of 8 months with no new safety signals\n\nLOTIS-7: Study design of trial evaluating ZYNLONTA\u00ae in patients with r\/r non
https://www.reddit.com/r/Merlynews/comments/16frdzl/good_lotr_vibes/